RN

Rabab Nasrallah

Principal at Earlybird Venture Capital

Germany

Investor
VC

Invests in

Locations:

Germany

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biochemistry
Molecular Biology
Cell Biology
Cell Culture
Polymerase Chain Reaction (PCR)
Western Blotting
Life Sciences
Research
Science

Education

Work Experience

Earlybird Venture Capital

2020

  • Investment Professional

    2020

Prothea Technologies

2024

  • Board Observer

    2024

Grey Wolf Therapeutics

2023

  • Member Board of Directors

    2023

ImCheck Therapeutics

2022

  • Board Observer

    2022

Priothera SAS

2020

  • Board Observer

    2020

INCUBATE

2019 - 2020

  • Research Engagement

    2020 - 2020

  • Program Manager

    2019 - 2020

    Design programmes that can support startup founders in developing their business models. Establishing new relationships with research communities to shape the future growth phase of INCUBATE. Identify and engage key stakeholders within new ecosystems to support INCUBATE's growth agenda.

The George Institute for Global Health

2019 - 2020

  • Strategy Research Associate

    2019 - 2020

The Babraham Institute

2016 - 2019

  • Babraham Institute Knowledge Exchange and Commercialisation committee member

    2018 - 2019

    Reviewing funding applications to support translational innovation projects.

  • Postdoctoral Research Scientist

    2016 - 2019

University of Cambridge

2017 - 2018

  • Commercialisation and market research for Medical i-Teams Cambridge

    2017 - 2018

    Investigating the commercial potential and landscape of emerging medical technologies.

The University of Manchester

2014 - 2014

  • Postdoctoral Research Scientist, CRUK Manchester

    2014 - 2014

    Stem cell biology research in the Lab of Dr. Georges Lacaud, Valerie kouskoff, and John Pimanda